Case Study: S&P 500 Pharmaceuticals Company achieves faster vendor onboarding and reduced risk assessment turnaround with Prevalent

S&P 500 Pharmaceuticals Company - Customer Case Study

S&P 500 Pharmaceuticals Company faced lengthy, manual vendor onboarding and complex spreadsheet-based assessment processes while needing to evaluate vendor cybersecurity. To address these vendor risk management challenges the company engaged Prevalent and adopted Prevalent’s vendor risk assessment/vendor risk management process.

Prevalent provided real-time cybersecurity, reputational and financial intelligence and clear inherent risk visibility, streamlining intake, scoring, assessment and remediation. As a result, Prevalent reduced assessment turnaround times “immensely,” cut the time and complexity of vendor risk assessments, enabled the team to work more effectively, and delivered major cost savings.